63
Participants
Start Date
December 31, 2009
Primary Completion Date
July 31, 2010
Study Completion Date
July 31, 2010
Octaplas LG
Octaplas LG was composed of human coagulation-active plasma treated with solvent/detergent for 1-1.5 hours to remove enveloped viruses, eg, HIV, HBV, and HCV. An additional manufacturing step, involving an affinity ligand gel, removed prion proteins. Octaplas LG was provided frozen in pyrogen free plastic bags.
Octaplas SD
Octaplas SD was composed of human coagulation-active plasma treated with solvent/detergent for 4-4.5 hours to remove enveloped viruses, eg, HIV, HBV, and HCV. Octaplas SD was provided frozen in pyrogen free plastic bags.
Department of Clinical Pharmacology - Medical University Vienna, Vienna
Lead Sponsor
Octapharma
INDUSTRY